FOLH1 and urogenital neoplasm: Prostate-specific membrane antigen (PSMA) RNA aptamers allowed for specific targeting and delivery of the siRNA to PSMA+ prostate xenograft tumors in nude mice using LNCaP-LN3 cells.30